Category ""
ADVERTISING
Administration of antihemophilic factor (recombinant) increases plasma levels of factor VIII and temporarily corrects the coagulation defect in patients with hemophilia A. Although similar in structure and pharmacologic effects to plasma-derived human factor VIII, antihemophilic factor (recombinant) is associated with substantially reduced risk ...
How should I use recombinant antihemophilic factor? Your doctor will perform a blood test to make sure recombinant antihemophilic factor is the right treatment for your clotting factor deficiency. Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.
Rebinyn ®, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B (congenital Factor IX deficiency) for on demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to ...
takeda.com DownloadADYNOVATE (Antihemophilic Factor (Recombinant), PEGylated) Page 1 of 33. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . ADYNOVATE® Antihemophilic Factor (Recombinant), PEGylated . Lyophilized Powder for Solution . 250, 500, 750, 1000, 1500, 2000, and 3000 IU/vial, Intravenous . Antihaemorrhagic Blood Coagulation Factor VIII
fda.gov DownloadThe recombinant Antihemophilic Factor Concentrate (For Further Manufacturing Use), is produced by Baxter Healthcare Corporation and Wyeth BioPharma (For Further Manufacturing Use) and subsequently ...